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a b s t r a c t
Peste des petits ruminants virus (PPRV) causes a fatal disease in small ruminants. V protein of PPRV plays
a pivotal role in interfering with host innate immunity by blocking IFNs signaling through interacting
with STAT1 and STAT2. In the present study, the results demonstrated that PPRV V protein blocks IFN
actions in a dose dependent manner and restrains the translocation of STAT1/2 proteins. We speculate
that the translocation inhibition might be caused by the interfering of the downstream of STAT protein.
Mutagenesis deﬁnes that Cys cluster and Trp motif of PPRV V protein are essential for STAT-mediated IFN
signaling. These ﬁndings give a new sight for the further studies to understand the delicate mechanism
of PPRV to escape the IFN signaling.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Peste des petits ruminants virus (PPRV) causes a fatal disease in
small ruminants, especially in goats and sheep, resulting in serious
economic loss (Wang et al., 2009; Peste des petits ruminants).
PPRV belongs to Morbillivirus of the Paramyxoviridae family and
contains a non-segmented negative strand RNA genome, which
encodes six structural proteins (N, P, M, F, H, L) and two non-
structural proteins (C, V) (Diallo et al., 1994; Gibbs et al., 1979;
Siddappa et al., 2014; Mahapatra et al., 2003; Bailey et al., 2005). In
Paramyxovirus, non-structural protein V shares an approximately
50% identical conserved C-terminal domain (CTD), CTD includes
one of an important zinc ﬁnger fold structure which contains a
zinc binding domains constituted by one histidine and seven
cysteine residues (Liston and Briedis, 1994; Paterson et al., 1995).
The previous studies showed that V protein played an important
role in interfering with an interferon (IFN)-mediated immune
system (He et al., 2002; Wansley and Parks, 2002; Poole et al.,
2002; Sun et al., 2004; Fontana et al., 2008; Ramachandran et al.,
2008; Chinnakannan et al., 2013; Takaki et al., 2011; Nakatsu et al.,
2008; Caignard et al., 2007; Devaux et al., 2007; Rodriguez and
Horvath, 2013).
IFNs, especially type I IFN (IFN-α/β) mediate the innate antivirus
responses (Cardenas, 2010; Wang et al., 2010; Takaki et al., 2013). IFNs
recognize the receptor leading to the activation and signal transduc-
tion of the receptor associated JAK-Tyk2 kinase, which phosphorylates
signal transducer and activator of transcription 1 (STAT1) and STAT2.
Both STAT1 and STAT2 interact with each other and are then
translocated into the nucleus, and assemble with IFN regulatory factor
9 (IRF9) to form a transcription factor complex, ISGF3, which is
responsible for binding the IFN stimulated response element, leading
to an antiviral status. It has been demonstrated that Morbilliviruses
develop three different strategies to evade IFN antiviral effects:
suppression of IFNs induction (Huang et al., 2014; Ning et al., 2014;
Komatsu et al., 2004; Ikegame et al., 2010); inhibiting IFN-induced
antiviral proteins (Zhao et al., 2013; Metz et al., 2012); interfering IFN
signal transduction (Sun et al., 2004; Ramachandran et al., 2008;
Chinnakannan et al., 2013; Nakatsu et al., 2008; Devaux et al., 2007). In
most cases, these activities are caused by V protein, although viral P
protein and C protein have been reported to be involved (Devaux et al.,
2007; Yamaguchi et al., 2014).
Recent study revealed that the V proteins of Rinderpest virus (RPV),
Measles virus (MV), PPRV and Canine distemper virus (CDV) could all
interfere with phosphorylation of the interferon-receptor-associated
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kinase Tyk2 and efﬁciently block IFNs-induced STAT1/2 phosphoryla-
tion. Morbillivirus V proteins showed variable capabilities of binding
STAT1/2 and exhibit multiple mechanisms to block IFNs signaling
pathways. MV V protein contributes to the inhibition of the IFN
antiviral state through binding with STAT1/2 to prevent nuclear
translocation of STAT proteins (Chinnakannan et al., 2013). It has been
demonstrated that MV V protein inhibits JAK1-mediated phosphor-
ylation of STAT1 to antagonize signaling transduction of type I IFN (I-
IFN) (Caignard et al., 2007). However, another report has showed that
MV V protein targets STAT2 to block IFN signaling (Ramachandran et
al., 2008). The zinc ﬁnger domain in MV V protein is necessary to bind
STAT2 and disrupts IFN signaling transduction. Several speciﬁc resi-
dues within the CTD domain of V protein are found to be critical to
inhibit the ability to associate with STAT2.
Despite an important role of PPRV proteins interacting with
host proteins in evasion of IFN-induced antivirus effects, little is
known about the mechanism for interaction of PPRV V protein
with STATs. To test the hypothesis that PPRV V protein might have
evolved to use speciﬁc function sites to inhibit STAT signaling, V
protein-dependent inhibition of IFN actions were investigated. In
the present study, PPRV V protein was found to inﬂuence the IFN
signaling transduction by interacting with STAT1/2. In addition,
PPRV V protein was also able to disturb the distribution of STAT
protein. The STAT1 and STAT2 contact site was mapped to N
terminal and/or C terminal. It was found that conserved Cys
cluster and Trp motif in V protein were involved in interacting
with STAT2, and amino acid 275 and 277 of V protein may play a
critical role in blocking IFN actions. These data suggest that these
important sites may participate in innate immune evasion.
Results
PPRV V protein inhibits type I IFN production and blocks its activation
In order to understand capability of PPRV V protein to inhibit
induction of type I IFN induction, Cos7, HEK293T and A549 cells
were used because of their susceptibility to PPRV infection. (Cos7,
Fig. 1A, A549 cells and HEK293T cells, data not shown). Cos7 cells
are unable to produce IFN but respond to exogenous IFN-β
stimulation. Therefore, to investigate if PPRV V protein was able
to inhibit induction of type I IFN induction, HEK293T cells were
used. The cells were initially treated with Sendai virus (SeV) which
is able to induce a large number of IFNs to induce IFNs and then
infected with PPRV. The CPE was monitored for seven days. As
shown in Fig. 1B, HEK293T cells treated without SeV appeared to
detach earlier than those cell treated with SeV. Interestingly, PPRV
signiﬁcantly decreased the production of IFN-α/β induced by SeV
(Fig. 1C). These data suggested that PPRV is able to interfere
productions of IFN-α/β. To identify which PPVR protein is involved
in inhibition of IFN production, HEK293T cells were transfected
with the IFN-β luciferase reporter plasmid (pRL-TK-luc, 0.1 μg)
either alone or together with plasmids expressing PPRV individual
protein (N, F, H, M, V and P) and control plasmid. At 24 h post-
transfections, cells were infected with SeV. The luciferase activity
was measured at 24 h after infection. As shown in Fig. 1D, PPRV V
protein was able to signiﬁcantly inhibit IFN-α/β production
induced by SeV. Similar results were observed in A549 cells (data
not shown). The results are correlated with previous studies with
MV that type I IFN production was interfered by MV V protein
(Takaki et al., 2011). Furthermore, to investigate whether the
proteins of PPRV was able to antagonize type I and type II IFNs
actions, H293K cells were transfected with the pISRE-luc or pGAS-
Luc plasmid alone or in the presence of plasmids expressing PPRV
individual protein (N, F, H, M, V and P) and control plasmid. At 24 h
post-infection, cells were treated with 1000 U/ml of IFN-β or IFN-γ
for 24 h and then the luciferase activity was measured. It was
found that stimulation of cells with IFN-β effectively activated the
transcription of ISGF3 responsive ISRE-luciferase reporter gene
(Fig. 1E) while IFN-γ effectively activated a STAT1-dependent γ-IFN
activation promoter sequence (GAS)-luciferase reporter gene
(Fig. 1F). However, PPRV V can signiﬁcantly inhibit IFN actions
although PPRV P, N proteins can also interfere IFN actions (Fig. 1E
and F). Taken together, the results demonstrated that PPRV is able
to use their own proteins to inhibit IFN production and block IFN
activations in infected cells.
PPRV V protein blocks IFNs signaling transduction by inhibition of
STAT1/2 translocation in a dose-dependent manner not a degradation
way
It is known that IFNs bind to the receptors when they are
secreted from the infected cells and signals to adjacent cells.
Induction of antiviral effects by IFNs requires coordinated and
cooperative action of the STAT1 and STAT2 (STAT1 and STAT2:
STAT1/2). The results above indicated that PPRV proteins are
sufﬁcient to suppress STAT-dependent signaling. Overexpression
of PPRV V protein can inhibit both IFNs-triggered activation of ISRE
and GAS promoter. As shown in Fig. 2A, overexpression of PPRV V
protein strongly inhibits IFN-α/β-induced activation of the ISRE
promoter in a dose-dependent manner in HEK293 cells (Fig. 2A).
Meanwhile, overexpression of PPRV V protein also inhibits IFN-γ-
induced activation of the GAS promoter (data not shown). Previous
study demonstrated that PPRV blocks IFN-induced phosphoryla-
tion of STAT1/2 for its nuclear translocation (Chinnakannan et al.,
2013). To determine the abilities of different domains of PPRV V
protein to block IFN-induced translocation of STAT1/2, HA-tagged
PPRV V protein and Flag-tagged STAT1/2 proteins from Cos7 cells
was used. The subcellular localization of both V protein and STAT
protein were detected by immunoﬂuorescence assay as described
above. As shown in Fig. 2B and C, type I IFN-induced STAT protein
translocation were blocked by V protein and also suppressed by
PNT and VCT (both are also called VNT and CTD, respectively)
domains of V protein. Intact V protein and its PNT and VCT were
detected in both nucleus and cytoplasm without induction of type
I IFN. In the context of confocal data, the results demonstrated that
STAT1 and STAT2 shuttle between cytoplasm and nucleus. In
response to stimulation with type I IFN in control cells, the
distribution of STAT1 and STAT2 did not apparently change. In
cells expressing PPRV V protein or PNT or VCT, STAT protein failed
to translocate into nucleus after stimulation with type I IFN. These
results revealed that PPRV V protein was involved in redistribution
of the STAT protein. PNT blocks translocation of STAT1 nucleus
while VCT changes distribution of STAT2. STAT1/2 were phos-
phorylated under condition of IFN treatment, then together with
IRF9, assemble into a complex known as ISGF3. ISGF3 rapidly
translocates into nucleus and binds to ISRE sequences to increase
transcription rates of the type I IFN stimulated gene. These results
above indirectly demonstrated that PPRV V protein blocks the type
I IFN-induced phosphorylation of STAT proteins which was found
by Senthil et al. (Chinnakannan et al., 2013). Quantitatively, based
on 60 cells expressing the V protein and STAT protein, PPRV V, PNT
and VCT showed 70%, 42% and 75% of cells with a complete change
in type I IFN induced redistribution of STAT protein. It has been
reported STAT1/2 proteins were targeted by V protein of Para-
myxoviridae. Viruses adopt V proteins to degrade STAT protein by
an ubiquitin system as one of the strategies to change transloca-
tion and accumulation of STAT protein within the nucleus (Randall
and Goodbourn, 2008; Palosaari et al., 2003; Takeuchi et al., 2003;
Didcock et al., 1999). To verify whether PPRV V protein changes
STAT protein distribution via degradation, a proteasomal activity
inhibitor MG132 was used to investigate degradation of the STAT
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protein (Fig. 2D). The PPRV V protein and STAT1 or STAT2 were co-
expressed in Cos7 cells, HA-IP was carried out to detect Flag
tagged-STAT proteins. As Fig. 2D shown, PPRV V protein was able
to block accumulation of STAT protein within nucleus but not by
degradation. Taken together, these data suggest that PPRV V
protein negatively regulates IFNs-triggered activation of ISRE and
GAS promoter and inhibits nuclear translocation of STAT protein
by non-degradation.
Contribution of both the PNT and VCT domains of PPRV V protein to
inhibit IFN-α/β signaling transduction through association with STAT
protein
It was found that PNT domain and VCT domain in MV V protein
contribute to the inhibition of type I IFN signal transduction
(Andrejeva et al., 2002). Therefore, a luciferase assay was used to
test whether PNT and VCT domains of PPRV V protein was able to
inhibit the type I IFN signaling pathway. As shown in Fig. 3A, both
PNT and VCT of PPRV V protein antagonize type I IFN signaling
transduction. It also showed that PNT domain only partial inhib-
ited type I IFN signaling transduction. Comparatively, VCT domain
appears to be more effective in term of inhibition of IFN-α/β
signaling transduction. In analysis of association of PNT and VCT
domains with STAT protein, it was found that PNT domain
interacted with STAT1 but did not with STAT2 (Fig. 3B). Because
of failure to detect the molecular weight of VCT, the GST pull down
experiment was then used. The result showed that interaction of
VCT domain with STAT2 protein occurred (Fig. 3C). Meanwhile,
results as shown in Fig. 2B and C demonstrate that PNT blocks
nucleus translocation of STAT1 and VCT inhibits accumulation of
STAT2 within cell nucleus. These results support that PNT inhibits
type I IFN actions through association with STAT1 and blocks
STAT1 translocation into nucleus. Unlike PNT, VCT to inhibit type I
IFN actions through association with STAT2 and changes distribu-
tion of the STAT2 protein. These results suggest that PNT and VCT
domains inhibit IFN transduction and redistribution of STAT
protein in different ways.
PPRV V protein binds with STAT1 protein via a conserved Tyr amino
acid residue, while a conserved Trp motif and Cys cluster are essential
for STAT2 association
To examine if PPRV V protein Cys cluster contributes to binding
STAT protein, Cys/Ala mutation plasmids were generated.
Fig. 1. PPRV V protein inhibits type I IFN production and blocks type I IFN activation. (A) Cos7 cells were infected with PPRV. Cells were stained with antisera to PPRV
nucleoprotein N (green) and stained nuclei with DAPI (blue). Merge of the two staining is shown on the right panel. (B) HEK293T cells morphology infected by SeV in prior to
PPRV became irregular rapidly. (C) PPRV interferes the production of IFN-α/β induced by SeV. HEK293T cells were transfected with IFN-β luciferase reporter plasmid, at 18 h
post-transfection, cells were either infected with PPRV or left uninfected. At 36 h post-infection, cells were infected with SeV for 12 h and then luciferase activity was
measured. Graph shows mean7SD, n¼3. (D) Screening proteins of PPRV which interfere the production of IFN-β induced by SeV. (E and F) Identiﬁcation of proteins of PPRV
which interfere the actions of IFNs. The results represent mean7SD for triplicate samples.
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Alignment of the members of Paramyxoviridae showed conserved
amino acid residues in V proteins and some conserved motifs were
found to signiﬁcantly interact with STAT protein (Ramachandran
et al., 2008; Nishio et al., 2005). For instance, human parainﬂuenza
virus type 2 (hPIV2) V protein can interacts with STAT1/2 via Trp
motif. Meanwhile, Y110H acid residue of hPIV2 V protein is an
important residue for STAT1 interaction (Nishio et al., 2005). MV V
protein inhibits STAT1/2 proteins shuttle between cytoplasm
and nucleus and interacts with STAT1/2 proteins with different
ways (Ramachandran et al., 2008; Palosaari et al., 2003). So we
Fig. 2. PPRV V protein blocks IFNs signaling transduction in a dose-dependent manner by inhibition of STAT1/2 translocation not in a degradation way. (A) PPRV V protein
inhibits the activation of the ISRE promoter induced by type I IFN in a dose-dependent manner. (þ) treated and () left untreated. Graph shows mean7SD, n¼3. (B) PPRV V
protein cannot inhibit the nuclear translocation of STAT1/2 without type I IFN treated. (C) PPRV V protein inhibits nuclear translocation of STAT1/2 proteins induced by IFN-α/
β. (D) PPRV V protein combines with STAT protein but not promotes STAT protein degradation. Immunobloting of STAT1, GAPDH and V protein.7V-HA DNA transfection of
Cos7 cells, and all the cell sample transfected with STAT1-FLAG, treated7MG132 for 4 h.
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speculate that similar amino acid residues might be essential for
PPRV V protein to bind with STAT protein. To address it, after
generation of deletion and substitution mutants, V-HA mutation
was co-expressed with Flag-tagged STAT1 or STAT2 in Cos7 cells.
Co-IP and pull-down were used to test which motif or amino-acid
residues in PPRV V protein contributes to the binding ability to
STAT protein. As shown in Fig. 4, when Trp amino-acid residues of
V protein (W240A/W250A) was mutated, no V protein-STAT complex
was observed, indicating that Trp motif of C terminal domain of PPRV
V protein was essential to form V protein-STAT complex. The
conserved Trp motif upstream of the Cys cluster contains two
residues, W240 and W250, but some of Paramyxoviruses V proteins
have another conserved Trp amino-acid residue W178. In PPRV V
protein, alignment with other Paramyxoviruses, this conserved site
residue is substituted by L236. Substitution mutants in which Trp
residue were replaced by Ala acid residue, was then constructed in
order to examine the role of Trp residues in binding STAT1/2. The
results revealed that single Trp substitution resulted in loss of the
ability of PPRV V protein to associate with STAT2 but do not affect
association with STAT1. Interestingly, W250A mutant decreased the
binding afﬁnity to STAT1 protein. When the D248 site of PPRV V
protein was replaced for Ala, PPRV V protein with replacement of the
D248F lost binding afﬁnity to STAT2. H232 of PPRV V protein could
form a zinc structure with Cys cluster, therefore we replaced some of
Fig. 3. Contribution of both the PNT and VCT domains of PPRV V protein to inhibit IFN-α/β signaling transduction through association with STAT protein. (A) Luciferase assay
was used to test whether PNT and VCT domains of PPRV V protein are able to inhibit the type I IFN signaling pathway. (B) Use co-immuniprecipitate to verify PNT associate
with STAT1 protein but not STAT2. (C) Use pull-down experiment to verify VCT associates with STAT2 and PNT does not interact with STAT2. All of the other mutations
interact with STAT2.
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the Cys acid residues to Ala in order to destroy the zinc structure. As
show in Fig. 4A and C, H232A and Trp-replacement mutations could
result in losing the ability to bind with STAT2 but not with STAT1.
Furthermore, replacement of Cys of C255/C272/C269-C276 to Ala, lead
to lose the ability to interact with STAT2 (Fig. 4E). These results
indicate that formation of PPRV V and STAT2 complex requires an
intact Cys residues. When other acid residues was replaced to Ala
between the ﬁrst and second zinc ﬁngers through alignment viruses
of Paramyxoviridae abilities of binding with STAT1/2 proteins did not
changed, indicating that these amino acid residues were not involved
in the association with STAT1/2 (Fig. 4B and D).
The results above (Fig. 2B and C) suggested that PPRV V protein
was able to interfere distribution of STAT proteins. Therefore, the
abilities of mutations were further tested using immunoﬂuores-
cence assay to explore if type I IFN-induced nuclear translocation
of STAT1 and STAT2 was blocked. In Fig. 4E, mutations at 255/250/
236 in PPRV V protein were applied as examples for the phenom-
enon. Results were coincident with the results above that Try
motif and Cys amino acid residues are required for translocation of
STAT2. Taken together, these results suggest that Cys cluster/Trp
motif and D248 in zinc structure play important roles in STAT2
binding afﬁnity and distribution but did not interfere the function
of STAT1. However, Y110 is the speciﬁc binding site for V protein-
STAT1complex.
Mutations of V protein result in lost the abilities to block type I IFN
action
As previous reports, the conserved regions in MV V protein
showed different inhibitions of the IFN-α/β signaling. To verify the
activity of the conserved regions of PPRV V protein on IFN-α/β
signaling, abilities of PPRV V protein and its mutants to block IFN
action were compared. For this purpose, reporter gene assays was
used for analysis of type I IFN induced transcription and a more
biologically relevant assay was employed to test their abilities to
block the induction of the antiviral status mediated by type I IFN
using VSV-GFP reproduction experiment.
Cos7 cells expressing the indicated PPRV mutant V proteins were
plated in a 96-well plate. At 24 h cells were treated with 10, 100,
1000 IU/ml of IFN-β for 12 h and then challenged with VSV-GFP at a
MOI of 0.1 for 16 h. The results showed that V protein and its mutants
were expressed at similar levels (Fig. 5A). Based on type I IFN-induced
gene transcription, it was found that wild type V protein, D248F, Trp
and Cys mutations inhibit the IFN-α/β signaling. In contrast, other
Fig. 4. Zinc structure of PPRV V protein is essential for formation of V protein-STAT2 complex formation. (A) Mutations were generated by site substitution to test the
function of Trp motif and Y110 amino acid residue for binding STAT1 protein. (B) Site mutations were generated to test the role of ﬁnger domain in binding STAT1 protein
process. (C) Like (A) but test the ability of V mutations combines with STAT2 protein. (D) Same site mutations from (B), using Co-IP assay to test the abilities of mutations to
bind with STAT2 protein. (E) Mutations of C255/C272/C269-276 of V proteins do not have abilities to block the association with STAT2. (F) Mutations of V proteins have
different abilities to block the translocation of STAT2. The 255/250 mutants do not interfere translocation of STAT2, but L236 mutant still has the ability to block the STAT2
translocation.
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mutations had a little impact on their ability to inhibit the IFN-α/β
signaling (Fig. 5B). This result is as uniformly as GFP expression
(Fig. 5C). In further analysis of some of the mutations, it was found
that site of mutations of Trp motif and zinc ﬁngers are essential for
establishment of the IFN-induced antiviral state. Moreover, Y110 and
D248 also affect VSV replication.
Discussion
PPRV infection leads to serious consequences for the host,
including suppression of the immunity system, especially innate
immunity. Many pathogenic viruses have evolved various strate-
gies to evade the innate immune system. It is known that most of
the sub-family Paramyxovirinae viruses have adopted effective
ways to antagonize the host immune system. The ﬁrst approach
used is to inhibit the function of IFN-induced host antivirus
proteins by viral protein (Takaki et al., 2011; Rodriguez and
Horvath, 2013); as well as to antagonize the IFN production
(Poole et al., 2002; Takaki et al., 2011; Rodriguez and Horvath,
2013). Most of RPV, MV, CDV and PPRV antagonize the production
of type I IFN. The result in the present study shown PPRV can block
the IFN-β production that induced by SeV (Fig. 1B). The third
strategy is to target the IFN signaling transduction by interacting
with the components of IFN signal transduction pathway or
inducing ubiquitination of proteins within IFN pathway. In this
case, V proteins of the Paramyxovirinae sub-family can directly
combine with the cellular STAT protein that is responsible for IFN
transduction inhibition.
PPRV V protein is a potent inhibitor of IFN transduction path-
way that hijack cellular proteins (Chinnakannan et al., 2013),
however, different viruses or the different strains of same genus
virus or the same virus studied by different laboratory may varied
(Ulane and Horvath, 2002). Experiments with luciferase assay in
the present study demonstrated that only PPRV V protein inter-
feres with the production of IFN-β. PPRV N, P, V proteins can
restrict the ISRE and GAS promoter expression to limit the IFN
signaling transduction, but in comparison with N, P proteins, V
protein has the strongest ability to block the IFN signaling,
especially, type I IFN-dependent pathway. The results also showed
that N and P proteins were able to inhibit ISRE more effectively
than GAS promoter, maybe due to the fact that STAT2 protein is
the primary target for N and P proteins-mediated type I IFN
signaling inhibition. This hypothesis needs to be conﬁrmed.
Finally, these results suggest that PPRV might have different ways
to ensure effective inhibition of IFN activation.
In Paramyxoviridae viruses, the strategy of V protein inhibits
antiviral state at least in part by targeting at both STAT1 and STAT2.
For instance, transient expression of the V protein of simian virus 5
(SV5) can inhibit activation of IFN-β response and SV5V protein
degrade the STAT1 protein to block IFN signaling transduction. Mumps
virus (MuV) and simian virus 41 (SV41) also decrease the STAT1
expression level. Remarkably, hPIV2 V protein dose not target STAT1
but STAT2 to antagonize IFN signaling. As previous studies demon-
strated that MV V protein targets STAT2 precede over STAT1 to inhibit
IFN-α/β signaling (Poole et al., 2002; Ramachandran et al., 2008;
Martens and Howard, 2006; Cardenas, 2010; Wang et al., 2010;
Takaki et al., 2013). Some viruses of Paramyxoviriuses interfere IFN
actions by disturbing STAT protein distribution. MV V protein con-
tributes to the inhibition of the IFN signaling through binding with
STAT1/2 to prevent nuclear translocation of STAT proteins
(Chinnakannan et al., 2013), and the PNT and VCT of MV V protein
bind with STAT1 and STAT2 respectively (Ramachandran et al., 2008).
The subcellular distribution of PPRV V protein is similar with MV, but
Fig. 5. Mutations of PPRV V protein result in loss of the abilities to block type I IFN action. (A) PPRV V protein and its mutants with HA tag were expressed at similar levels;
(B) the same experiment process like above for ISRE-luc luciferase assay but use mutation V proteins; (C) VSV-GFP infection assay for the type I IFN-induced antiviral status.
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distinct from that of Rubulavirus genus and Henipavirus genus. PPRV V
protein has no effect on nuclear distribution of STAT protein without
IFN induction. In other Paramyxovirus, V proteins function to redis-
tribute STAT protein which can be interfered by leptomycin B (LMB),
but for MV V protein interferes with STAT protein nuclear shuttling
being independent on a chromosomal region maintenance 1 (Crm1)
nuclear export system (Palosaari et al., 2003). V protein is conserved
between PPRV and MV, especially VCT domain. So we speculated that
PPRV V protein may have the same mechanism as MV in STAT protein
redistribution. V protein of Paramyxovirus also antagonize IFN actions
through interfering phosphorylation of STAT protein or accelerate
degradation of STAT protein to actively interfere its anti-IFN activity
(Ramachandran et al., 2008; Caignard et al., 2007; Devaux et al., 2007;
Martens and Howard, 2006; Precious et al., 2005). For the hPIV2, V
protein is associated with STAT1/2 proteins and the VCT domain
strongly affects the degradation of STAT2 protein (Ulane and Horvath,
2002). Our results (Fig. 2B and C) lead to a concept whether V protein
may degrade STAT1 and STAT2 protein by the ubiquitin system.
However, PPRV V protein does not inhibit IFN signaling by degradation
of STAT. Recent studies revealed that MV, RPV and Henipavirus (HeV) V
proteins sequester STAT protein to block them from translocating into
nuclear without degradation. It has been demonstrated that MV V
protein inhibits Jak1-mediated phosphorylation of STAT1 to antagonize
type I IFN signaling transduction (Caignard et al., 2007). However,
another report has veriﬁed that MV V protein is the primary target of
STAT2 to block IFN signaling (Ramachandran et al., 2008). Meanwhile,
VCTof PPRV V protein antagonizes STAT2 protein nuclear translocation.
Previous study shows that VCT does not interact with JAK kinase
(Caignard et al., 2007). So this means that VCT does not induce the
STAT2 ubiquitination and VCTalso does not inhibit the activation of JAK
kinase. From results we know that PPRV V protein may interfere with
the upstream or the downstream of STAT protein to block STAT protein
nuclear translocation. Here we conjecture that PPRV may regulate the
downstream of STAT protein within the host. PPRV may also regulate
the nuclear import proteins. As previous studies revealed that Nuclear
localization signal (NLS) or Npap60/Nup50 plays a critical role in
disassembly of nuclear protein import complex (Nishio et al., 2005;
Matsuura and Stewart, 2005), we speculate that failure of STAT1 and
STAT2 proteins to be imported to nuclear may be caused by V protein
which interferes with the function of NLS or NSL binding protein
karyopherin-α or cofactor protein Npap60/Nup50. Further studies are
required to dissect the principle of V protein to block the translocation
(Fig. 6). This study may give a new insight into better understanding
the intricate and delicate mechanism of PPRV to escape the IFN
signaling.
Previous reports demonstrated that both the C- and N-terminal
domains of Morbillivirus V protein contribute to inhibition of the
IFN signaling (Ramachandran et al., 2008). Like MV, the results
showed that PNT and VCT of PPRV V protein play a critical role in
interfering with STAT1/2. PNT domain combines with STAT1 rather
than STAT2, while the VCT domain interacts with STAT2 instead of
STAT1. A mutation that deleted the Y110H of the PNT of MV V
protein impaired its ability to bind with STAT1 and decreased the
inhibition of the IFN signaling. In the present study, we demon-
strated that the PPRV V protein mutation which substitute the
Y110 to Ala acid residue impaired its ability to inhibit the IFN
signaling, which is in agreement with previous studies which
showed that the speciﬁc domain of V protein is important for its
anti-IFN activity and required for interacting with STAT proteins
(Ramachandran et al., 2008; Devaux et al., 2007; Matsuura and
Stewart, 2005; Nishio et al., 2002; Nishio et al., 2001).
The ﬁnger structure of V protein is essential for interacting with
STAT protein. The Cys cluster is the most notable feature of the V
proteins of Paramyxovirus. This cluster binds two zinc ions to
establish a Ring ﬁngers structure. In Paramyovirus, the VCT also
contains a Trp motif in the upstream of the Cys cluster, but in
PRRV, one of the Trp residue was substituted by leucine acid
residue and formed a new Trp motif (L-X3-W9-W) (Andrejeva et
al., 2002). Here we constructed some of V protein mutations that
are conserved in ﬁnger structure to verify the critical role of these
binding sites. The results demonstrated that any of the Trp
residues of Trp motif is sufﬁcient for PPRV V protein interacting
with STAT2 protein and blocking the IFN signaling. However, the
Leu residue within Trp motif is not required for IFN-induced signal
transduction. Meanwhile, the conserved acid residues was
selected to conﬁrm which one is critical for the STAT protein
binding, indicating that Cys cluster as well as Trp motif are
required in PPRV-induced anti-IFN activity. But interestingly, 275
and 277 acid residues site within V protein are more prone to
interfere with the IFN signaling. Finally, both PNT and VCT of PPRV
V protein were identiﬁed to play a synergistic role in innate
immune evasion. Moreover and Trp motif and Cys cluster in zinc
ﬁnger structure of PPRV V protein are essential for this IFNs
evasion.
Materials and methods
Cell culture
Cos7, A549 and HEK293T were used in experiments. Cells were
maintained in 1640 medium (Hyclone) supplemented with 10%
fetal bovine serum (Gibco-BRL) and incubated with 5% CO2.
Growth of viruses was performed on Cos7 cells.
Recombinant constructs
N, F, H, M and P genes of PPRV also were cloned into pCAGGs.
PPRV Tibet strain V gene (gb|FJ905304.1) and N terminal domain of
V gene (PNT, 1-231aa) and C terminal domain of V gene (VCT, 232-
299aa), STAT1 and STAT2 gene fragments were all cloned into
pCAGGs plasmid with HA or Flag tag. Meanwhile, intact V gene
recombinant construct (V-HA-pCAGGs) was used as template to
Fig. 6. The way of PPRV V protein blocks IFN signaling. (1) V protein blocks JAK-
mediated STAT1 phosphorylation to inhibit IFN signaling. (2) V protein interacts
with STAT1/2 to block IFN signaling or interacts with DDB1 to facilitate STAT2
degradation. (3) PPRV V protein blocks STAT proteins to translocate into nuclear
and recently studies showed V protein could inhibit JAK-mediated STAT1 phos-
phorylation, but another report suggested STAT2 is the primary target for the
interaction by V protein, we speculate that V protein inhibits STAT protein
translocation may have another way through interfering the function of karyo-
pherin or other importin proteins.
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make the different point mutants. All of the point mutations from
V gene were performed to substitute an Ala acid residue. V, PNT,
VCT genes and point mutation of V gene were cloned into a
prokaryotic expression vector (pGEX4T-1). All the recombinant
plasmids were veriﬁed by DNA sequencing (Genewiz).
Transfection
Transient transfection of cells was carried out using lipofecta-
mine 2000 (Invitrogen) according to manufacture's instruction.
Luciferase assay
Luciferase assay was performed as previously described
(Caignard et al., 2007). Brieﬂy, Cells (A549 or HEK293T) were
plated in 24-well culture plates. After 24 h, cells were co-
transfected with 1 μg per well of a recombinant plasmid, 0.01 μg
of pRL-TK and 0.1 μg of either pIFN-β-luc or pISRE-luc or pGAS-luc.
At 24 h post transfection, culture medium was replaced with fresh
medium supplemented with 1000 U/ml of IFN-(α/β). After 18 h
treatment with IFNs, the luciferase activity was analyzed using a
Dual-Glo luciferase assay system (Promega).
Immunoprecipitation (IP)
Cos7 cells were seeded in 6-well culture plates. After 24 h, cells
were co-transfected with (per well) 2 μg of plasmid containing of
either wild-type V gene or mutation V gene, and 2 μg of Flag
tagged STAT1/STAT2 constructs or empty vector as indicated. At
24 h post transfection, culture medium was replaced with fresh
medium containing 1000 U of IFN-(α/β)/ml. After 18 h, cell
extracts were pre-cleared with protein A/G Sepharose beads
(Abmart), supernatant incubated with HA antibody (Sigma) and
fresh protein A/G Sepharose beads for 2 h. After incubation and
wash steps, precipitates were used for western blot analysis.
GST pull-down
GST pull-down was performed as previously described
(Sambrook and Russell, 2006). Brieﬂy, the E. coli-expressed
V-GST or point mutation GST fusion protein was puriﬁed and co-
mixed with Cos7 expressing STAT1 or STAT2 protein, Flag antibody
and fresh protein A/G. Precipitates were analyzed by western blot.
Western blot
Proteins and beads complex with sodium dodecyl sulfate
loading buffer, IP samples were separated with Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
detected using immunoblotting. The results of immunoblotting
visualized by chemiluminescence. Anti-HA, anti-Flag and anti-GST
of antibodies were purchased from Sigma.
Indirect immunoﬂuorescence and laser scanning confocal microscope
Cos7 cells were seeded on glass circle cover slip (Fisher) and
infected with PPRV at a MOI of 0.1 or co-transfected with plasmid
expressing V or V mutation proteins and either of STAT1 or STAT2
as described above. 24 h after transfection, cells were washed with
PBS, ﬁxed, permeabilized and probed with HA or FLAG and DAPI
(Sigma). Images were obtained using a Leica TCSSP confocal
microscope for indirect immunoﬂuorescence and ZEISS LSM 710
for confocal.
Antiviral assays
Antiviral responses were measured by vesicular stomatitis
virus containing green ﬂuorescent gene (VSV-GFP). Brieﬂy, Cos7
cells were transfected with empty vector, wild-type (WT) V
protein or mutant V for 24 h. Then cells were pretreated with
IFN for 8 h. Cells were washed with IPTG-MEM medium and
incubated with 9105 PFU/well recombination VSV-GFP for 1 h
at 37 1C and then cultured in IPTG-MEM medium. At 18 h post-
infection, the cells were observed and photographed.
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